Dawn Biopharma

🗓 Founded 2022👥 2 employees💰 Last funded Dec 2021
Biotechnology
LinkedIn
Dawn Biopharma is a platform controlled by the KKR Healthcare Strategic Growth Fund II, established to own a diverse portfolio of companies committed to the development of innovative medicines and therapies. Dawn Biopharma aims to provide flexible capital to innovators and thought leaders across the life sciences ecosystem with a shared vision of delivering life-changing medicines to patients in need.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2022
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Dawn Biopharma?
Dawn Biopharma has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Dawn Biopharma last raise funding?
The most recent investment in Dawn Biopharma recorded on gritt.io was in December 2021.
When was Dawn Biopharma founded?
Dawn Biopharma was founded in 2022.
What industry is Dawn Biopharma in?
Dawn Biopharma operates in Biotechnology. Find similar Biotechnology investors on gritt.io.